Physician profile
Gehan Ibrahim
NPI 1538405147
$371.72
in general payments reported to CMS, 2019-2025
11 companies · $17.00 in 2025
The $17.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $67.92 · 2021: $74.23 · 2022: $12.26 · 2023: $31.41 · 2024: $35.98 · 2025: $17.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $77.16 | 2019 | |
| Abbvie INC. | $77.05 | 2019-2021 | |
| Lupin INC. | $44.20 | 2019-2020 | |
| Exeltis, USA INC. | $34.70 | 2024-2025 | Slynd |
| Medtronic, INC. | $31.41 | 2023 | Minimed 780g |
| Evofem Biosciences, INC. | $28.21 | 2021 | |
| Myovant Sciences INC. | $20.41 | 2021 | |
| Astellas Pharma US INC | $18.28 | 2024 | Veozah |
| Coopersurgical, INC. | $14.40 | 2021 | |
| Merck Sharp & Dohme LLC | $13.64 | 2020 | |
| Avion Pharmaceuticals | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gehan Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.